Federal Register / Vol. 75, No. 250 / Thursday, December 30, 2010 / Notices 82405 

likely than other children to be irritable 

or to have mild, temporary diarrhea or 

vomiting. This happens within the first 

week after getting a dose of the vaccine. 

Serious Problems: Some studies have 

shown a small increase in cases of 

intussusception during the week after 

the first dose. Intussusception is a type 

of bowel blockage that is treated in a 

hospital. In some cases surgery might be 

required. The estimated risk is 1 case 

per 100,000 infants. 

What if my child has a severe reaction? 

What should I look for? 

Any unusual condition, such as a 

high fever or behavior changes. Signs of 

a severe allergic reaction can include 

difficulty breathing, hoarseness or 

wheezing, hives, paleness, weakness, a 

fast heart beat or dizziness. 

What should I do? 

Call a doctor, or get the person to a 

doctor right away. 

Tell the doctor what happened, the 

date and time it happened, and when 

the vaccination was given. 

Ask your doctor to report the reaction 

by filing a Vaccine Adverse Event 

Reporting System (VAERS) form. Or you 

can file this report through the VAERS 

Web site at http://www.vaers.hhs.gov, or 

by calling 1–800–822–7967. VAERS 

does not provide medical advice. 

The National Vaccine Injury 

Compensation Program 

The National Vaccine Injury 

Compensation Program (VICP) was 

created in 1986. 

People who believe they may have 

been injured by a vaccine can learn 

about the program and about filing a 

claim by calling 1–800–338–2382, or 

visiting the VICP Web site at http://

www.hrsa.gov/vaccinecompensation. 

For More Information 

• Ask your doctor. They can give you 

the vaccine package insert or suggest 

other sources of information. 

• Call your local or state health 

department. 

• Contact the Centers for Disease 

Control and Prevention (CDC): 

—Call 1–800–232–4636 (1–800–CDC– 

INFO) or 

—Visit CDC’s Web site at http://www.

cdc.gov/vaccines. 

Department of Health and Human 

Services 

Centers for Disease Control and 

Prevention 

Vaccine Information Statement 

(00/00/0000) (Proposed) 

42 U.S.C. 300aa–26 

Dated: December 21, 2010. 

Tanja Popovic, 

Deputy Associate Director for Science, 

Centers for Disease Control and Prevention 

(CDC). 

[FR Doc. 2010–32965 Filed 12–29–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

Statement of Organization, Functions, 

and Delegations of Authority 

Part F of the Statement of 

Organization, Functions, and 

Delegations of Authority for the 

Department of Health and Human 

Services, Centers for Medicare & 

Medicaid Services (CMS), (last amended 

at 75 FR 14176–14178, dated March 24, 

2010) is amended to change the title of 

the Office of Executive Operations and 

Regulatory Affairs to the Office of 

Strategic Operations and Regulatory 

Affairs, to reflect the establishment of a 

new Federal Coordinated Health Care 

Office and to update the organization for 

CMS, as follows: 

(1) Under Part F, CMS, FC. 10 

Organizations, change the title of the 

Office of Executive Operations and 

Regulatory Affairs (FCF) to the Office of 

Strategic Operations and Regulatory 

Affairs (FCF). 

(2) Under Part F, CMS, FC. 10 

Organizations, insert the following new 

Office after the Center for Medicare and 

Medicaid Innovation (FCP): ‘‘Federal 

Coordinated Health Care Office (FCQ).’’ 

(3) Under Part F, CMS, FC. 20 

Functions, change the title of the Office 

of Executive Operations and Regulatory 

Affairs (FCF) to the Office of Strategic 

Operations and Regulatory Affairs 

(FCF). 

(4) Under Part F, CMS, FC. 20 

Functions, insert the following after the 

description of the Center for Medicare 

and Medicaid Innovation (FCP): 

Federal Coordinated Health Care Office 

(FCQ) 

• Manages the implementation and 

operation of the Federal Coordinated 

Health Care Office mandated in section 

2602 of the Affordable Care Act, 

ensuring more effective integration of 

benefits under Medicare and Medicaid 

for individuals eligible for both 

programs and improving coordination 

between the Federal Government and 

States in the delivery of benefits for 

such individuals. 

• Monitors and reports on annual 

total expenditures, health outcomes and 

access to benefits for all dual eligible 

individuals, including subsets of the 

population. 

• Coordinates with the Center for 

Medicare and Medicaid Innovation to 

provide technical assistance and 

programmatic guidance related to the 

testing of various delivery system, 

payment, service and/or technology 

models to improve care coordination, 

reduce costs, and improve the 

beneficiary experience for individuals 

dually eligible for Medicare and 

Medicaid. 

• Performs policy and program 

analysis of Federal and State statutes, 

policies, rules and regulations 

impacting the dual eligible population. 

• Makes recommendations on 

eliminating administrative and 

regulatory barriers between the 

Medicare and Medicaid programs. 

• Develops tools, resources and 

educational materials to increase dual 

eligibles’ understanding of and 

satisfaction with coverage under the 

Medicare and Medicaid programs. 

• Provides technical assistance to 

States, health plans, physicians and 

other relevant entities of individuals 

with education and tools necessary for 

developing integrated programs for dual 

eligible beneficiaries. 

• Consults with the Medicare 

Payment Advisory Commission and the 

Medicaid and CHIP Payment Advisory 

Commission with respect to policies 

relating to the enrollment in and 

provision of benefits to dual eligible 

beneficiaries under Medicare and 

Medicaid. 

• Studies the provision of drug 

coverage for new full benefit dual 

eligible individuals. 

• Develops policy and program 

recommendations to eliminate cost 

shifting between the Medicare and 

Medicaid program and among related 

health care providers. 

• Develops annual report containing 

recommendations for legislation that 

would improve care coordination and 

benefits for dual eligible individuals. 

Authority: 44 U.S.C. 3101. 

Dated: December 7, 2010. 

Kathleen Sebelius, 

Secretary. 

[FR Doc. 2010–32957 Filed 12–27–10; 4:15 pm] 

BILLING CODE 4120–01–P 


jlentini on DSKJ8SOYB1PROD with NOTICES